CCn1nc(C)c2c(-c3ccccc3)cc(=O)n(C(C)C(=O)NCc3cccc(OC)c3)c21
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?